Skip Navigation LinksHomeProductsProduct Details
Product In-Details

Salofalk ® 500 tablets

MINAPHARM- Egypt(under license of Dr. Falk- Germany) was honored since the beginning of this millennium to introduce to the Egyptian Pharmaceutical Market the branded Mesalazine, Salofalk®; The Active Principle where it is required.

Ingredient: Mesalazine 500mg
Multinational Partner: Dr. Falk Pharma
Launch Date: January 1, 2000
Pack: Salofalk® is available in a box of two strips, each strip contains ten enteric-coated tablets.

Product General

Disease Area

Salofalk is indicated in (IBD) Inflammatory Bowel Diseases: 

(1) Crohn's Disease.

(2) Ulcerative Colitis.

Where the normal mucosal homeostasis is altered with reduced ability of the GIT to distinguish foreign from self-antigens, or to down-regulate the mucosal immune response. This makes the self-limited Immune Elimination process proceeds to the Amplification Phase then to the Damage Phase.

Insert leaflet


Prophylaxis and treatment of IBD recurrence (Ulcerative Colitis). Treatment of acute attacks of Crohn's disease.


1.5 gm to 4 gm daily according to severity 1 hour before eating.

Latest Products Read More »

Newsletter Sign-up

Stay connected, subscribe to our newsletter
for news and updates.


Office Address

El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis,
Cairo - Egypt.
Phone:(+202) 2414-3170/1/2/3/4/5
Fax:(+202) 2414-3179